These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG). Werbrouck C; Evangelista CCS; Lobón-Iglesias MJ; Barret E; Le Teuff G; Merlevede J; Brusini R; Kergrohen T; Mondini M; Bolle S; Varlet P; Beccaria K; Boddaert N; Puget S; Grill J; Debily MA; Castel D Clin Cancer Res; 2019 Nov; 25(22):6788-6800. PubMed ID: 31481512 [TBL] [Abstract][Full Text] [Related]
7. Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma. Cao H; Jin M; Gao M; Zhou H; Tao YJ; Skolnick J Sci Rep; 2020 Apr; 10(1):6140. PubMed ID: 32273545 [TBL] [Abstract][Full Text] [Related]
8. A kinome-wide shRNA screen uncovers vaccinia-related kinase 3 (VRK3) as an essential gene for diffuse intrinsic pontine glioma survival. Silva-Evangelista C; Barret E; Ménez V; Merlevede J; Kergrohen T; Saccasyn A; Oberlin E; Puget S; Beccaria K; Grill J; Castel D; Debily MA Oncogene; 2019 Sep; 38(38):6479-6490. PubMed ID: 31324890 [TBL] [Abstract][Full Text] [Related]
11. Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma. An S; Camarillo JM; Huang TY; Li D; Morris JA; Zoltek MA; Qi J; Behbahani M; Kambhampati M; Kelleher NL; Nazarian J; Thomas PM; Saratsis AM J Exp Clin Cancer Res; 2020 Nov; 39(1):261. PubMed ID: 33239043 [TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry. Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282 [TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG). Giagnacovo M; Antonelli M; Biassoni V; Schiavello E; Warmuth-Metz M; Buttarelli FR; Modena P; Massimino M Childs Nerv Syst; 2020 Apr; 36(4):697-704. PubMed ID: 31848724 [TBL] [Abstract][Full Text] [Related]
14. Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib. Wang Z; Xu C; Diplas BH; Moure CJ; Chen CJ; Chen LH; Du C; Zhu H; Greer PK; Zhang L; He Y; Waitkus MS; Yan H Mol Cancer Res; 2020 Jul; 18(7):968-980. PubMed ID: 32229503 [TBL] [Abstract][Full Text] [Related]
15. Context-dependent tumor-suppressive BMP signaling in diffuse intrinsic pontine glioma regulates stemness through epigenetic regulation of CXXC5. Sun Y; Yan K; Wang Y; Xu C; Wang D; Zhou W; Guo S; Han Y; Tang L; Shao Y; Shan S; Zhang QC; Tang Y; Zhang L; Xi Q Nat Cancer; 2022 Sep; 3(9):1105-1122. PubMed ID: 35915262 [TBL] [Abstract][Full Text] [Related]
16. Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas. Chung C; Sweha SR; Pratt D; Tamrazi B; Panwalkar P; Banda A; Bayliss J; Hawes D; Yang F; Lee HJ; Shan M; Cieslik M; Qin T; Werner CK; Wahl DR; Lyssiotis CA; Bian Z; Shotwell JB; Yadav VN; Koschmann C; Chinnaiyan AM; Blüml S; Judkins AR; Venneti S Cancer Cell; 2020 Sep; 38(3):334-349.e9. PubMed ID: 32795401 [TBL] [Abstract][Full Text] [Related]
17. Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics. Hoffman LM; DeWire M; Ryall S; Buczkowicz P; Leach J; Miles L; Ramani A; Brudno M; Kumar SS; Drissi R; Dexheimer P; Salloum R; Chow L; Hummel T; Stevenson C; Lu QR; Jones B; Witte D; Aronow B; Hawkins CE; Fouladi M Acta Neuropathol Commun; 2016 Jan; 4():1. PubMed ID: 26727948 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Piunti A; Hashizume R; Morgan MA; Bartom ET; Horbinski CM; Marshall SA; Rendleman EJ; Ma Q; Takahashi YH; Woodfin AR; Misharin AV; Abshiru NA; Lulla RR; Saratsis AM; Kelleher NL; James CD; Shilatifard A Nat Med; 2017 Apr; 23(4):493-500. PubMed ID: 28263307 [TBL] [Abstract][Full Text] [Related]
20. Dimethyl alpha-ketoglutarate inhibits proliferation in diffuse intrinsic pontine glioma by reprogramming epigenetic and transcriptional networks. Lee K; Yun S; Park J; Lee S; Carcaboso AM; Yi SJ; Kim K Biochem Biophys Res Commun; 2023 Oct; 677():6-12. PubMed ID: 37523894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]